Aspartic proteinases form a widely distributed protein superfamily, including cathepsin D, cathepsin E, pepsins, renin, BACE and napsin. Human napsin genes are located on human chromosome 19q13, which comprises napsin A and napsin B. Napsin B has been annotated as a pseudogene because it lacks an in-frame stop codon; its nascent chains are cotranslationally degraded. Until recently, there have been no studies concerning the molecular evolution of the napsin protein family in the human genome. In the present study, we investigated the evolution and gene organization of the napsin protein family. Napsin B orthologs are primarily distributed in primates, while napsin A orthologs are the only napsin genes in other species. The corresponding regions of napsin B in the available sequences from primate species contain an in-frame stop codon at a position equivalent to that of human napsin A. In addition, a rare single-nucleotide polymorphism (SNP) that creates a proper stop codon in human napsin B was identified using HapMap populations.
Introduction
Aspartic proteinases are acidic proteolytic enzymes that have a bilobal structure with two domains (Hsu et al., 1977) . The active site of the aspartic proteinase contains two aspartate residues positioned in the middle of a cleft between the N-and C-terminal domains of the molecule and is partially covered by a hairpin loop, termed the flap or S1 subsite, protruding from the N-terminal domain (Sepulveda et al., 1975) . Aspartic proteinases form a multigenic family that is widely distributed in organisms, and the major members of this family can be arranged into distinct clusters of orthologous groups, including cathepsin D, cathepsin E, nothepsin, renin, BACE, pepsin, and the fetal forms, pepsin Y and pepsin F (Borrelli et al., 2006; Carginale et al., 2004; Kageyama, 2002; Vassar et al., 1999; Xin et al., 2000) .
The human napsin A (NAPSA) transcript is primarily expressed in the lung and kidney, but minor expression of NAPSA has also been observed in the prostate, connective tissue and the eye. NAPSA is expressed in alveolar type II cells and well-differentiated lung adenocarcinomas, whereas NAPSA expression is weak in poorly differentiated tumors, making this protein a promising diagnostic marker for primary lung adenocarcinomas (Chuman et al., 1999; Dejmek et al., 2007; Hirano et al., 2003; Ueno et al., 2008) . It has also been shown that NAPSA protein is present in human urine. The napsin B (NAPSB) transcript is predominantly expressed in blood and lymphoid tissues, such as tonsil, lymph node, bone marrow, and spleen. In humans, the NAPSA and NAPSB genes are tandemly located on chromosome 19q13. The napsin genes contain nine exons, and NAPSA and NAPSB have the same exon organization. Rodents express a single napsin, designated napsin A (Napsa). Thus, Tatnell et al. (1998) proposed that NAPSA and NAPSB were derived from a relatively recent gene duplication event, in evolutionary terms, after the divergence of mice and humans, though the exact duplication timing and process are unknown until now. NAPSB has been annotated as a pseudogene because it lacks an inframe stop codon at a position equivalent to that of human NAPSA (Tatnell et al., 1998) .
Recently, it has been reported that chimpanzee NAPSB contains an in-frame stop codon, suggesting that chimpanzee NAPSB encodes a functional aspartic protease (Puente et al., 2005) . The reference allele at polymorphic sites has been defined using the most common allele obtained from the alignment of multiple individual genome sequences. However, the major allele encodes a loss-of-function variant, reflecting an inherent bias toward annotating functional genes in the reference genome; thus, events that might lead to gene inactivation are largely overlooked in automatic annotation processes (Balasubramanian et al., 2011) . In this context, NAPSB orthologs in other species are typically annotated as NAPSA-like genes, and no NAPSB orthologs have been described in other species. Here, we investigated the evolution and gene organization of the two napsins, NAPSA and NAPSB, and traced the evolutionary origin of the subfamily of these genes in animals. Moreover, we compared the enzymatic activity and three-dimensional structure of the NAPSA and NAPSB proteins. Table 1 . The nucleotide sequences adjacent to poly(A) at the 3'-terminus were aligned manually. Predicted or known nucleotide and protein sequences for the identified loci were aligned using ClustalW.
Sequence analysis
The alignment of the napsin amino acid sequences and related proteases was performed in ClustalW using standard settings (Gonnet weight matrix, gap opening=10 and gap extension = 0.2). All positions containing gaps and missing data were eliminated. The analysis involved 34 amino acid sequences. There were a total of 282 positions in the final dataset. The evolutionary history was inferred using two methods. A Neighbor-Joining (NJ) tree (Saitou and Nei, 1987) was reconstructed in MEGA5 (Tamura, et al., 2011) . The bootstrap consensus tree inferred from 1000 replicates (Felsenstein, 1985) represented the evolutionary history of the taxa analyzed (Felsenstein, 1985) . The evolutionary distances were computed using the Dayhoff matrix-based method (Schwarz and Dayhoff, 1979) and are presented as the number of amino acid substitutions per site. The rate variation among sites was modeled with a gamma distribution (shape parameter = 2). The same alignment was also used to generate a Maximum Likelihood (ML) tree based on the Jones model (Jones, et al., 1992) . Initial tree(s) for the heuristic search were obtained automatically using the following method. When the number of common sites was < 100 or less than one fourth of the total number of sites, the maximum parsimony method was used; otherwise, the BIONJ method was used, with an MCL distance matrix. A discrete Gamma distribution was used to model evolutionary rate differences among sites (4 categories (+G, parameter = 1.8314)). The trees were drawn to scale, with branch lengths representing the number of substitutions per site. The trees were reconstructed using FigTree version 1.3.1 (http://tree.bio.ed.ac.uk/software/figtree/). We estimate synonymous and non-synonymous substitution rates as pairwise comparisons between sequences, using codeml program (run mode = -2, CodonFreq = 2), that is included in PAML 4.6 package (Yang, 2007) . Codonbased Z-test to selection (P < 0.05) was carried out by using MEGA5 to estimate nucleotide sequence distances from synonymous and non-synonymous sites with the Nei-Gojobori model in standard error determined from 1000 bootstrap replicates (Nei and Gojobori, 1986 ).
Comparative genomics and neighboring gene families
The synteny of the NAPSA and NAPSB loci and their flanking genes was obtained using the NCBI Map Viewer and Ensembl Genome Browser.
Three-dimensional comparative modeling
The crystal structure of human renin (PDB: 1hrn) was used as a template for 3D modeling. Homology modeling of NAPSA and NAPSB was performed using the SWISS-MODEL Workspace (Arnold et al., 2006) . Based on the results obtained, NAPSA and NAPSB were superimposed with human pepsin A (PDB: 1pso) using the PyMOL Version 1.5.0.3 (Schrödinger). (IMAGE: 5757357), encoding NAPSA and NAPSB, respectively, were purchased from Invitrogen. The putative full-length region encoding NAPSA was PCR-amplified from the BI824756 clone using the Pfu Turbo high-fidelity polymerase (Stratagene) according to the manufacturer's instructions with the primers NapsEcor1atgF (5'-TGCTGGAATTCCCGGGATGTCTCCACCAC-3'; the EcoRI site is underlined) and NapsaXhoR (5'-TAGTCCTCGAGGAACTGCGCCTGCGCAG-3'; the XhoI site is underlined). The PCR products were digested with EcoRI and XhoI. A linker containing the DYKDDDDK sequence was prepared from two annealed oligonucleotides: xhoIFLAGxbaIF (5'-TCGAGGACTACAAGGACGACGATGATAAGTGAT-3'; the XhoI site is underlined, and the FLAG coding sequence with a stop codon is italicized) and xhoIFLAGxbaIR (5'-CTAGATCACTTATCATCGTCGTCCTTGTAGTCC-3'; the XbaI site is underlined, and the complementary FLAG coding sequence with a stop codon is italicized). The PCR product and linker were subcloned into the EcoRI-XbaI sites of pcDNA3 (Invitrogen). The NAPSB-FLAG construct was constructed from the BQ073045 clone as described above, except NapsbxhoR (5'-TAGTCCTCGAGGTACTGCGCCTGCGCGGTC-3'; the XhoI is site underlined) was used as a reverse primer. The XhoI site introduced into NAPSA-FLAG was subsequently restored to the wild type sequence using the QuikChange site-directed mutagenesis kit (Stratagene) and the primer pair 5'-GCAGGCGCAGTTCCCCGGGGACTACAAGGACG-3' (the wild-type sequence is underlined) 5'-CGTCCTTGTAGTCCCCGGGGAACTGCGCCTGC-3'(the wild-type sequence is underlined).
Transfection and purification of recombinant NAPSA and NAPSB
Human HEK293 cells were transfected with the NAPSA-FLAG-pcDNA3 or NAPSB-FLAG-pcDNA3 vector using SuperFect (Qiagen) according to the manufacturer's instructions. The cells were incubated with G418 sulfate, and the G418-resistant colonies were screened through a proteinase assay (see below) or Western blotting using anti-napsin antibodies or the anti-DYKDDDDK (Wako Chemicals) antibody. The lysate from cells transfected with NAPSA-FLAG was centrifuged, adsorbed to anti-FLAG M2 beads and washed with RIPA buffer. The FLAG-containing proteins were eluted using Tris-buffered saline containing 100 μg/ml 3X FLAG peptide (Sigma) or 3 M sodium isothiocyanate.
Protease assay
The aspartic protease activity was determined fluorometrically using intramolecularly quenched peptide substrates. The cell extracts or fractions of the FLAG affinity gel were preincubated with leupeptin for 10 min. The commercially available aspartic proteinase substrates (MOCAc-Ala-Pro-Ala-Lys-Phe-Phe-Arg-Leu-Lys(Dnp)-NH 2 , proteinase A and pepsin, 3216-v; MOCAc-Gly-Lys-Pro-Ile-Leu-Phe-Phe-Arg-Leu-Lys(Dnp)-D-Arg-NH 2 , cathepsin D/E, 3200-v; MOCAc-Gly-Ser-Pro-Ala-Phe-Leu-Ala-Lys(Dnp)-D-Arg-NH 2 , cathepsin E, 3225-v; and MOCAc-Ser-Glu-Val-Asn-Leu-Asp-Ala-Glu-Phe-Arg-Lys(Dnp)-Arg-Arg-NH 2 , BACE, 3212-v; Peptide Institute) were subsequently added and incubated for up to 2 h. At the end of the incubation, the fluorescence was measured at 328 nm and 393 nm as excitation and emission wavelengths, respectively, using a fluorescence spectrophotometer F4000 (Hitachi). The background measurement was conducted using the same manner as described above, except 1 μM of pepstatin A (an aspartic protease inhibitor, Peptide Institute) was added during the preincubation.
Results

A SNP of human napsin B pseudogene that restores the functional gene
The human reference genome is a haploid sequence derived as a composite from multiple individuals. However, the major allele encodes a loss-of-function variant, reflecting an inherent bias toward annotating functional genes in the reference genome; thus, events that might lead to gene inactivation are largely overlooked in automatic annotation processes (Balasubramanian et al., 2011) . A search for the SNP in the human dbSNP Build 137 database revealed a SNP, rs11879785, that converts the human NAPSB pseudogene to a functional gene. Fig. 1 represents a world map that shows the allele frequency obtained from the HapMap populations (Altshuler et al., 2010) . Yoruba in Ibadan, Nigeria (YRI) has the highest frequency of the active NAPSB form at 4.5%. In addition, the active allele was also identified in African Ancestry in SW USA (4.2%), Mexican Ancestry in Los Angeles, CA, USA (3.1%), Chinese in Metropolitan Denver, CO, USA (1.8%), and Gujarati Indians in Houston, Texas, USA (0.6%). The inactive allele was practically fixed in populations with Northern and Western European ancestry (CEU) and Far East Asians (HCB and JPT).
This annotation problem also contributes to erroneous gene annotation in other species.
A Blast search using the human NAPSA amino acid sequence revealed annotated or nonannotated genes from tetrapods and fishes but not from birds or invertebrates. To further identify non-annotated genes, blastn searches using the human NAPSB mRNA sequence to trace archive Whole Genome Shotgun submission databases were implemented. Several napsin genomic sequences were also available in the gorilla and green anole lizard, but their sequences were incomplete and thereby excluded from the analysis. The NAPSB orthologs were distributed only in primates, including the marmoset, while the NAPSA orthologs were the only napsin gene in other species, strongly supporting the idea of a recent duplication event. One exception is the prosimian primate greater galago genome, which contains only NAPSA (GenBank: NW_003852606). Because the sequence data are represented in an unplaced scaffold reference state, it was unclear whether the NAPSB was absent from the grate galago genome. Fig. 2 shows a comparison of the amino acid sequences of the napsins compared with those of the other aspartic proteases. The intramolecular disulfide bonds characteristic of mammalian aspartic proteinases are conserved in all napsins. Several potential N-linked oligosaccharide attachment sites were identified in the same location as the glycosylation motif in nothepsin and cathepsin E (at Asn26 in human NAPSA), human renin and cathepsin D (at Asn67 and Asn183, respectively), but not in other aspartic proteinases (Asn268). The RGD sequence is the most distinctive feature of the NAPSA, NAPSB, and mouse Napsa (Tatnell, et al., 1998) .
However, the RGD sequence is not conserved in all napsins; the sequence has been replaced with RGN in the dog and giant panda (not shown) and is completely absent in the platypus, frog, and fish (Fig. 2) . Similarly, the C-terminal extension of napsin is absent in the platypus, frog, and fish. The NAPSB contains a unique Arg at position 287, which we will discuss in section 3.5.
We also examined whether the pseudogenization of NAPSB is human-specific. Both NAPSA and NAPSB genes are located reciprocally on human chromosome 19q13 and are organized into nine exons ( Fig. 3 and 5) . The cDNA sequences of human NAPSA and NAPSB at their respective 3´ untranslated regions are both short, with 75% identity between the TGA/TGC codon and the AGTAAA putative polyadenylation site motif present in both sequences at approximately 20 bp upstream from the poly(A) tail. The sequence comparisons showed that the stop codon disruption in NAPSB is human-specific; the corresponding regions of NAPSB in the other available sequences of primate species contain an in-frame stop codon at a position equivalent to that of human NAPSA, ruling out an ancestral polymorphism (Fig. 3) . Collectively, these data strongly support the conclusion that a duplication event occurred during the early stages of primate evolution to generate NAPSB, followed by human-specific NAPSB pseudogenization.
Phylogenetic analyses of napsins
To clarify the duplication timings and the evolutionary relationships between NAPSA and NAPSB, we constructed phylogenetic trees using NJ and ML. Thus, potential inconsistencies, reflecting the use of a single method, were avoided. Each tree reconstitution showed similar relationships between the retrieved sequences, with minor differences. Both analyses identified two major clades: one clade comprising pepsins, cathepsin E, and nothepsin and the other clade included cathepsin D, cathepsin D2, napsin, and renins. The napsin clades were divided into three species: amniotes, frogs, and fish. A Sparus aurata gene annotated as cathepsin D (GenBank: AAB88862) was grouped with fish napsins and cathepsin D2 (Fig. 4) . Two polytomies remain unsolved: the napsin and cathepsin D clades represented a triplet branching pattern in the NJ tree and a quadruplet branching pattern in the ML tree. Adding more sequence data for the napsin orthologs might resolve these polytomies; however, we currently do not have enough sequence data.
Arrangement of napsin genes in vertebrate chromosomes
Existing unsolved polytomies prompted us to focus on the gene organization of napsin genes in four eutherian species (human, chimpanzee, marmoset, and mouse), a frog (clawed frog), and two fish (medaka and pufferfish), as the data could provide powerful insights with respect to gene origin. The napsin loci were well conserved between the various species, with two distinct settings. In the eutherian species, the napsin genes were located between the NR1H2 and KCNC3 genes. A partial cDNA sequence, GenBank accession number XM_002829607, was annotated as orangutan NAPSA, however, its genomic topology (KCNC3-XM_002829607-LOC100455861-NR1H2) suggested that this sequence represented an NAPSB ortholog. In fact, when this orangutan NAPSA sequence was used as a query, the top Blast hit was a chimpanzee NAPSB (GenBank: XP_530061), and the amino acid identities between orangutan NAPSA and chimpanzee NAPSB and NAPSA (GenBank: XP_524345) were 95% and 85%, respectively. A similar topology was observed in the genomes of the Western clawed frog (Fig. 5B ) and the anole lizard (Ensembl: ENSACAG00000005091), although these primary assembly units have not been identified in any assembled chromosomes or linkage groups. In medaka, an annotated napsin A gene located between ATF4 and SMCR7L was identified as similar to cathepsin D2 in pufferfish. However, in the corresponding region of the human chromosome (22q13), no napsins were located between these two genes (Fig. 5C ). These results indicate that the frog napsin gene is orthologous to the eutherian napsin, while the fish napsin clade, which contains cathepsin D2, is not an ortholog. However, it is certain that the napsin gene evolved from an ancestral protease, which could have been present before the divergence of amniotes from amphibians.
Evidence of purifying selection of the NAPSB gene
We next tested for evidence of the purifying selection by estimating the nonsynonymous/synonymous substitution rate (dN/dS ) distribution among amino acid sites.
Duplication has an important role in the creation of novel genes. Through the redundancy generated by duplication, one of the paralogous copies can escape the pressure of negative selection and accumulate. A codon-based test of purifying selection for analysis between NAPSA and NAPSB of 4 simian primate species is shown in Table 2 . Most of the dN/dS rates between each pair of napsin genes were significantly lower than 1.0. Interestingly, dN/dS rates (≈1) observed between macaque NAPSB and the other species' NAPSB indicate neutral selection. Among the non-synonymous substitutions in the macaque NAPSB, a lossof-function amino acid substitution occurred at one of the active site aspartates (Asp217, Figure 2 ). These results supports the notion that NAPSB is not just a duplicated copy of NAPSA and that the gene products of human NAPSB active allele and chimpanzee NAPSB may be functional. Nevertheless, the occurrence of two independent loss-of-function events of NAPSB in the primate species strongly suggests that the loss of NAPSB activity may be evolutionary advantageous.
Recombinant protein expression and analyses
As the pseudogenization event of NAPSB were both human-specific and nearly fixed, we explored the functional implications through the enzymatic activities of recombinant human NAPSA and NAPSB. Full-length NAPSA and NAPSB constructs were generated with a Cterminal FLAG tag to facilitate purification and expressed stably in HEK293 cells.
HEK293 cells do not express detectable NAPSA (Ueno et al., 2008) . Stably transfected clones were established and the protease activity in the cell extract (Fig. 6A ) or in partially purified fraction (Fig 6B) was assessed. NAPSA cleaved the synthetic substrates of BACE, proteinase A/pepsin, and cathepsin E; however, we could not detect proteolytic activity toward acid-denatured hemoglobin or ovalbumin, which is widely used as an aspartic proteinase substrate (data not shown). Notably, the cleavage sites KF-FR of 3216-v (proteinase A/pepsin substrate), IL-F-FR of 3200-v (cathepsin D/E substrate), and AF-LA of 3225-v (cathepsin E substrate) match the criteria for NAPSA cleavage sites (SchauerVukasinovic et al., 2000) , and this is the first report showing that NAPSA cleaves NL-D of 3212-v (BACE substrate, the Swedish mutation of amyloid precursor protein sequence).
The proteinase A/pepsin activity in the untransfected cells was attributed to endogenous cathepsin D. In contrast, the NAPSB activity toward aspartic proteinase substrates was marginal (Fig. 6) . However, the active site cleft of NAPSB appears to be accessible, as the NAPSB protein bound to the pepstatin A agarose gel (data not shown). Thus, we cannot rule out the possibility that NAPSB maintains their activity toward biological endogenous substrate(s).
Three-dimensional homology modeling
We next explored the differences in the 3D structure between NAPSA and NAPSB.
NAPSA and NAPSB were superimposed onto human pepsin A (PDB: 1pso) as shown in Fig. 7 . The napsin-specific RGD sequence located in the loop at top of the 3D structure was solvent-accessible. The aspartates in the catalytic site (shown in red sticks) were located within the substrate-binding cleft in the enzyme moiety and flanked by the S1 and S1' subsites. These subsites are involved in the binding of the substrate to the enzyme and play an essential role in substrate specificity (Khan, et al., 1997) . The S1 subsite (~Tyr75-Gly76-X-Gly78 in pepsin numbering) is conserved and is presented as a flexible loop. The S1'-loops of NAPSA (blue) and NAPSB (orange) are located more centrally than that of pepsin (green loop at left); thus, there is less space in the substrate binding clefts, which might explain why neither NAPSA nor NAPSB exhibit proteolytic activity toward the classical aspartic protease substrate hemoglobin. In addition, all primate NAPSB sequences present a unique Arg at position 287 (in pepsin numbering, shown in orange spheres). Arg is the most basic amino acid, and its side chain is longer than that of Gln, which is present in NAPSA and pepsin (shown in blue and magenta spheres, respectively) at the corresponding position. We also observed that the Arg287 narrows the substrate-binding cleft of NAPSB compared with that of NAPSA or pepsin (Fig. 7) . This distinct residue in the NAPSB sequences might result in the loss of catalytic activity toward the synthetic substrates tested here.
Discussion
In this study, we investigated the evolution and gene organization of the napsin protease family. NAPSB orthologs are primarily distributed in primates, while NAPSA orthologs are the only napsin genes in other species. The corresponding regions of NAPSB in the available sequences from primate species contain an in-frame stop codon at a position equivalent to that of human NAPSA. In addition, a rare SNP that creates a proper stop codon in human NAPSB pseudogene was identified using HapMap database. Thus, the minor allele encoding functional and evolutionarily conserved protein should be annotated as the gene. The human reference genome is a haploid sequence derived as a composite from multiple individuals. However, the major allele encodes a loss-of-function variant, reflecting an inherent bias toward annotating functional genes in the reference genome; thus, events that might lead to gene inactivation are largely overlooked in automatic annotation processes (Balasubramanian et al., 2011) . This problem also contributes to erroneous gene annotation in other species. In addition, the tandemly duplicated genes tend to collapse into one gene by low quality sequencing and assembly. In the case of NAPSB, we observed no NAPSB ortholog was annotated as NAPSB, because the reference gene (human NAPSB) is annotated as a pseudogene. Thus, annotation based on the current human reference genome does not provide an accurate and complete set of the genes found across all human populations (Balasubramanian et al., 2011) and the other species.
The phylogenetic analysis involved 35 amino acid sequences, including other members of aspartic proteases, and showed that napsin clades were divided into three species: amniotes, frogs, and fish. The fish napsin clade includes fish cathepsin D2, which has recently been identified in pufferfish as a paralog to cathepsin D (Kurokawa et al., 2005) . A recent phylogenetic study suggested that the cathepsin D2 gene was generated from a duplication event in the common ancestors of fish and tetrapods, followed by cathepsin D2 gene loss in birds and higher vertebrate lineages (Feng et al., 2011) . Consistent with this analysis, we observed that the tetrapod and fish napsins belong to distinct synteny groups, indicating a potential paralogous relationship between these genes.
Gene inactivation events can have varying effects on human phenotypes. The loss of function due to nonsense mutations has been implicated as disease causing in ~15%-30% of monogenic inherited diseases (Mort et al., 2008) . It was previously proposed that, in some cases, pseudogenization could confer a selective advantage. For example, the CASP12 gene, which encodes a cysteine protease, contains nonsense SNPs leading to premature stop codons that result in the presence of both the active and inactive forms of the genes in the human population. The premature stop variant in CASP12 is the most common allele in human populations, with a frequency of 100% in many Eurasian populations because it confers increased resistance to severe sepsis (Wang et al., 2005; Xue et al., 2006) . The NAPSB pseudogenization is also practically fixed in non-African populations. In addition, the human NAPSB transcript is specifically expressed in lymphoid tissues, suggesting the possibility that the pseudogenization of NAPSB was advantageous in recent human evolution, presumably against microbes and infections. It was suggested that the translationally active chimpanzee counterpart of this gene might contribute to some of the functional differences between the human and chimpanzee immune systems (Puente et al., 2005) . We report here that the enzymatic activity of human NAPSB is marginal, which most likely reflects the Arg287 substitution; however, we cannot rule out the possibility that human NAPSB maintains their activity toward biological substrate(s).Nonstop protein expression is low, and nonstop decay does not fully account for the low level of nonstop protein (Ito-Harashima et al., 2007) . Notably, despite the absence of a stop codon in the NAPSB gene, the NAPSB protein is expressed in HEK293 cells (patent: US 6225103). Our attempt to express the NAPSB protein encoded by the nonstop-poly(A) NAPSB cDNA was unsuccessful (data not shown). Nonstop mutations can lead to the continued and inappropriate translation of mRNA in the 3'-untranslated region. Nonstop mRNA is rapidly degraded, the translation of nonstop mRNA is repressed, and nonstop proteins are cotranslationally degraded (Ito-Harashima et al., 2007) . The current model suggests that a polylysine tag at the C-terminus of nonstop proteins, which results from the translation of the poly(A) tail, causes translational repression and the enhanced cotranslational degradation of the nascent peptide (Vasudevan et al., 2002) .
Another NAPSB SNP, rs634091, which converts the codon GGC to CGC (Gly122Arg), has been proposed; thus, the clone containing the minor allele Arg122 would not generate an active enzyme (Tatnell et al., 1998) . The Arg122 minor allele frequency is 0.07 in the HapMap YRI population. In the present study, the NAPSB cDNA clone (GenBank: BQ073045) contained Gly122 and nonstop (rs11879785) major alleles. The distance between rs634091 and rs11879785 is 3 kb. Thus, we attempted to identify haplotypes for the two SNPs in HapMap individuals of YRI (Altshuler et al., 2010) , and no individuals possessing both SNPs with minor alleles were found. Thus, it is reasonable to conclude that that Gly122Arg mutation was derived in a single individual with the rs1879785 major allele; that is, this mutation occurred more recently than the human-specific NAPSB pseudogenization. In addition, macaque NAPSB protein appears to have lost its protease activity by the active site amino acid substitution. These independent loss-of-function events of NAPSB in the primate species strongly suggests that the loss of NAPSB activity may be evolutionary advantageous.
Finally, we have found that the S1'-loops of NAPSA and NAPSB are located more centrally than those of pepsin in the 3D structure homology modeling. Some of the S1' residues are important for the specificity and catalytic efficiency of pepsin A and chymosin (Kageyama, 2004) . It has also been proposed that the wider substrate cleft of fish pepsin might accommodate larger substrates more efficiently, thus contributing to the specific activity toward larger substrates, such as hemoglobin and its digestion intermediates (Tanji et al., 2009 ). On the contrary, our 3D modeling of NAPSA and NAPSB revealed less space in the active site, and it would be interesting to elucidate in detail how the catalytic functions are affected, including the substrate specificity and the specific activity toward large substrates, such as hemoglobin. We also observed that the Arg287 narrows the substrate-binding cleft of NAPSB compared with that of NAPSA or pepsin. This distinct residue in the NAPSB sequences might result in the loss of catalytic activity toward biological endogenous substrate(s) tested in this study.
In summary, we conclude that the napsin family members have been present before the divergence of amniotes from amphibians. The NAPSB was duplicated from NAPSA during the early stages of primate evolution and the subsequent loss of the NAPSB function (i.e. protease activity) during primate evolution. We propose that a minor allele in human NAPSB and primate NAPSB orthologs, which create a proper stop codon, encode functional, and evolutionarily conserved protein should be annotated as the gene. The bound proteins were eluted using 3X FLAG peptide. The protease activity was measured using several commercial substrates was determined as described under "Materials and Methods 2.2.3". ALHAAIGGIPLLAGEYIIRCSEIPKLPA
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